CP Cerulean Pharma Inc. Stock: price and management transactions · United States · SEC (Form 4)Follow the Cerulean Pharma Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). The latest transaction was disclosed on 12 February 2016 (Acquisition). Among the most active insiders: WALT DAVID R. The full history is free.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 February 2016
All Executives29 Thresholds0 Prospectus0 Other0
Declarations 29 total
▲ Director · Executives · 10 Feb 2016
4,500 shares Common Stock SEC:0001209191-16-098014:0
Canonical exit: 10 May 2016 (T+90) ▲ Director · Executives · 11 Feb 2016
4,350 shares Common Stock SEC:0001209191-16-098014:1
Canonical exit: 11 May 2016 (T+90) ▲ Director · Executives · 8 Feb 2016
4,500 shares Common Stock SEC:0001209191-16-097270:0
Canonical exit: 8 May 2016 (T+90) ▲ Director · Executives · 9 Feb 2016
4,500 shares Common Stock SEC:0001209191-16-097270:1
Canonical exit: 9 May 2016 (T+90) ▲ Director · Executives · 5 Feb 2016
4,500 shares Common Stock SEC:0001209191-16-096365:1
Canonical exit: 5 May 2016 (T+90) ▲ Director · Executives · 4 Feb 2016
4,063 shares Common Stock SEC:0001209191-16-096365:0
Canonical exit: 4 May 2016 (T+90) ▲ Director · Executives · 2 Feb 2016
4,395 shares Common Stock SEC:0001209191-16-095726:0
Canonical exit: 2 May 2016 (T+90) ▲ Director · Executives · 3 Feb 2016
4,018 shares Common Stock SEC:0001209191-16-095726:1
Canonical exit: 3 May 2016 (T+90) ▲ Director · Executives · 29 Jan 2016
1,200 shares Common Stock SEC:0001209191-16-094706:0
Canonical exit: 28 Apr 2016 (T+90) ▲ Director · Executives · 1 Feb 2016
4,500 shares Common Stock SEC:0001209191-16-094706:1
Canonical exit: 1 May 2016 (T+90) ▲ Director · Executives · 27 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-094149:0
Canonical exit: 26 Apr 2016 (T+90) ▲ Director · Executives · 28 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-094149:1
Canonical exit: 27 Apr 2016 (T+90) ▲ Director · Executives · 25 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-093783:0
Canonical exit: 24 Apr 2016 (T+90) ▲ Director · Executives · 26 Jan 2016
4,300 shares Common Stock SEC:0001209191-16-093783:1
Canonical exit: 25 Apr 2016 (T+90) ▲ Director · Executives · 21 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-093420:0
Canonical exit: 20 Apr 2016 (T+90) ▲ Director · Executives · 22 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-093420:1
Canonical exit: 21 Apr 2016 (T+90) ▲ Director · Executives · 19 Jan 2016
4,400 shares Common Stock SEC:0001209191-16-092885:0
Canonical exit: 18 Apr 2016 (T+90) ▲ Director · Executives · 20 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-092885:1
Canonical exit: 19 Apr 2016 (T+90) ▲ Director · Executives · 14 Jan 2016
4,400 shares Common Stock SEC:0001209191-16-092049:0
Canonical exit: 13 Apr 2016 (T+90) ▲ Director · Executives · 15 Jan 2016
4,172 shares Common Stock SEC:0001209191-16-092049:1
Canonical exit: 14 Apr 2016 (T+90) ▲ Director · Executives · 12 Jan 2016
4,300 shares Common Stock SEC:0001209191-16-091409:0
Canonical exit: 11 Apr 2016 (T+90) ▲ Director · Executives · 13 Jan 2016
4,384 shares Common Stock SEC:0001209191-16-091409:1
Canonical exit: 12 Apr 2016 (T+90) ▲ Director · Executives · 8 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-090953:0
Canonical exit: 7 Apr 2016 (T+90) ▲ Director · Executives · 11 Jan 2016
4,355 shares Common Stock SEC:0001209191-16-090953:1
Canonical exit: 10 Apr 2016 (T+90) ▲ Director · Executives · 6 Jan 2016
4,500 shares Common Stock SEC:0001209191-16-090585:0
Canonical exit: 5 Apr 2016 (T+90) 25 of 29 declarations
Load more (4 remaining) 关于 Cerulean Pharma Inc. Cerulean Pharma Inc. 是一家生物制药公司，专注于开发创新的癌症治疗方法。该公司在纳斯达克上市，股票代码为 CRLN。